Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 195 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BREITHARDT G
    NOACs for Stroke Prevention in Atrial Fibrillation With Valve Disease: Filling the Gaps.
    J Am Coll Cardiol. 2017;69:1383-1385.
    PubMed     Text format    


  2. RENDA G, Ricci F, Giugliano RP, De Caterina R, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    J Am Coll Cardiol. 2017;69:1363-1371.
    PubMed     Text format     Abstract available


  3. LIM HS, Hocini M, Dubois R, Denis A, et al
    Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1257-1269.
    PubMed     Text format     Abstract available


  4. MILLER JM, Kalra V, Das MK, Jain R, et al
    Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry.
    J Am Coll Cardiol. 2017;69:1247-1256.
    PubMed     Text format     Abstract available


  5. ARBUSTINI E, Favalli V, Narula N, Serio A, et al
    Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1210-1211.
    PubMed     Text format    


  6. SCHWEIZER PA, Koenen M, Katus HA, Thomas D, et al
    A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1209-1210.
    PubMed     Text format    


    February 2017
  7. KABRA R, Girotra S, Vaughan Sarrazin M
    Reply: Race and Stroke Risk in Atrial Fibrillation: The Limitations of a Social Construct.
    J Am Coll Cardiol. 2017;69:907-908.
    PubMed     Text format    


  8. JOHNSON AE, Magnani JW
    Race and Stroke Risk in Atrial Fibrillation: The Limitations of a Social Construct.
    J Am Coll Cardiol. 2017;69:906-907.
    PubMed     Text format    


  9. DEEDWANIA P, Acharya T
    Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?
    J Am Coll Cardiol. 2017;69:786-788.
    PubMed     Text format    


  10. BONDE AN, Lip GY, Kamper AL, Staerk L, et al
    Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients.
    J Am Coll Cardiol. 2017;69:752-753.
    PubMed     Text format    


    January 2017
  11. PICCINI JP, Granger CB
    Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?
    J Am Coll Cardiol. 2017;69:420-422.
    PubMed     Text format    


  12. PATTI G, Lucerna M, Cavallari I, Ricottini E, et al
    Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
    J Am Coll Cardiol. 2017;69:409-419.
    PubMed     Text format     Abstract available


  13. VAUGHAN SARRAZIN MS, Jones M, Mazur A, Cram P, et al
    Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban.
    J Am Coll Cardiol. 2017;69:360-362.
    PubMed     Text format    


  14. HUMMEL J
    Substrate Ablation Without Pulmonary Vein Isolation: A Reasonable Proposition for Atrial Fibrillation Ablation?
    J Am Coll Cardiol. 2017;69:322-324.
    PubMed     Text format    


  15. GOLDBERGER JJ, Mitrani RD
    Autonomic Tone and Atrial Fibrillation: A Double-Edged Sword?
    J Am Coll Cardiol. 2017;69:300-302.
    PubMed     Text format    


  16. AGARWAL SK, Norby FL, Whitsel EA, Soliman EZ, et al
    Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up.
    J Am Coll Cardiol. 2017;69:291-299.
    PubMed     Text format     Abstract available


  17. BETZ JK, Katz DF, Peterson PN, Borne RT, et al
    Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry.
    J Am Coll Cardiol. 2017;69:265-274.
    PubMed     Text format     Abstract available


  18. DOHERTY JU, Gluckman TJ, Hucker WJ, Januzzi JL Jr, et al
    2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.
    J Am Coll Cardiol. 2017 Jan 5. pii: S0735-1097(16)37085.
    PubMed     Text format    


    December 2016
  19. VOSKOBOINIK A, Prabhu S, Ling LH, Kalman JM, et al
    Alcohol and Atrial Fibrillation: A Sobering Review.
    J Am Coll Cardiol. 2016;68:2567-2576.
    PubMed     Text format     Abstract available


  20. JAMES CA, Calkins H
    Further Progress in Predicting Life-Threatening Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2016;68:2551-2553.
    PubMed     Text format    


  21. MAZZANTI A, Ng K, Faragli A, Maragna R, et al
    Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    J Am Coll Cardiol. 2016;68:2540-2550.
    PubMed     Text format     Abstract available


  22. GOMEZ-OUTES A, Lagunar-Ruiz J, Terleira-Fernandez AI, Calvo-Rojas G, et al
    Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:2508-2521.
    PubMed     Text format     Abstract available


  23. KALMAN JM, Nalliah CJ, Sanders P
    Surgical Weight Loss and Atrial Fibrillation: A Convenient Paradigm to Evaluate a Complex Problem.
    J Am Coll Cardiol. 2016;68:2505-2507.
    PubMed     Text format    


  24. JAMALY S, Carlsson L, Peltonen M, Jacobson P, et al
    Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects.
    J Am Coll Cardiol. 2016;68:2497-2504.
    PubMed     Text format     Abstract available


  25. HSU JC, Maddox TM, Marcus GM
    Reply: Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2493.
    PubMed     Text format    


  26. BROWN JD, Shewale AR, Dherange P, Talbert JC, et al
    Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2492.
    PubMed     Text format    


    November 2016
  27. CHAN YH, Yeh YH, See LC, Wang CL, et al
    Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2016;68:2272-2283.
    PubMed     Text format     Abstract available


  28. KOTECHA D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, et al
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.
    J Am Coll Cardiol. 2016;68:2217-2228.
    PubMed     Text format     Abstract available


  29. MARCHLINSKI FE, Edvardsen T
    Arrhythmogenic Right Ventricular Cardiomyopathy: Better Tools for Detecting Early Disease and Progression.
    J Am Coll Cardiol. 2016;68:2198-2200.
    PubMed     Text format    


  30. MAST TP, Teske AJ, Walmsley J, van der Heijden JF, et al
    Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2016;68:2185-2197.
    PubMed     Text format     Abstract available


  31. SEEGER J, Gonska B, Rodewald C, Wolfgang Rottbauer, et al
    TCT-227 Apixaban in patients with atrial fibrillation after transfemoral aortic valve implantation compared with vitamin K antagonist.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  32. FAGGIONI M, Chandrasekhar J, Aquino M, Vogel B, et al
    TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  33. DORDI R, Kosmidou I, Redfors B, Dizon J, et al
    TCT-199 Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  34. PATEL N, Patel N, Arora S, Badheka A, et al
    TCT-118 Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  35. HENRY T, Patel A, Schaer G, DeMaria A, et al
    TCT-824 Reduction in Ventricular Arrhythmias with Ixmyelocel-T: Results from the IxCell-DCM Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  36. GHIRARDI G, Ferrari C, Pontone G, Trabattoni D, et al
    TCT-809 Stenting for the treatment of pulmonary vein stenosis after atrial fibrillation radiofrequency catheter ablation: initial experience with peripheral stents plus drug-coated balloons and coronary drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  37. KINDSVATER S, Squiers J, Tabachnick D, Brown DL, et al
    TCT-754 New Persistent Left Bundle Branch Block after Transcatheter Aortic Valve Replacement is Associated with High Rate of Mortality.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  38. SANNINO A, Stoler RC, Lima B, Szerlip M, et al
    TCT-648 Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  39. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-620 A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  40. REDDY V, Akehurst R, Gavaghan M, Amorosi S, et al
    TCT-617 Cost Effectiveness Following Treatment Initiation of Stroke Reduction Strategies in Non-Valvular Atrial Fibrillation: Warfarin vs NOACs vs Left Atrial Appendage Closure.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  41. PARK DW, Kang SH, Choi H, Ahn JM, et al
    TCT-327 Prevalence, Management, and Outcomes of Atrial Fibrillation Among Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  42. FRANCO LN, Sahay S, Rodes-Cabau J, Jimenez P, et al
    TCT-25 Efficacy and Safety of Left Atrial Appendage Closure Versus Medical Treatment in Atrial Fibrillation: A Network Metaanalysis From Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  43. REDDY VY, Gibson DN, Kar S, O'Neill W, et al
    Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36641.
    PubMed     Text format     Abstract available


  44. GOLLOB MH
    Toward Translation of Genomic Discovery to Clinical Efficacy in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1895-1897.
    PubMed     Text format    


    September 2016
  45. LAU YC, Proietti M, Guiducci E, Blann AD, et al
    Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2016;68:1452-64.
    PubMed     Text format     Abstract available


  46. CHAN YH, Kuo CT, Yeh YH, Chang SH, et al
    Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1389-401.
    PubMed     Text format     Abstract available


  47. GIERULA J, Paton MF, Byrom R, Cubbon RM, et al
    Reply: The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1253.
    PubMed     Text format    


  48. CERIT L
    The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1252-3.
    PubMed     Text format    


  49. ESCANDE W, Marijon E, Defaye P, Piot O, et al
    Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention.
    J Am Coll Cardiol. 2016;68:1248-50.
    PubMed     Text format    


  50. HYLEK EM, Ko D
    Atrial Fibrillation and Fall Risk: What Are the Treatment Implications?
    J Am Coll Cardiol. 2016;68:1179-80.
    PubMed     Text format    


  51. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
    J Am Coll Cardiol. 2016;68:1169-78.
    PubMed     Text format     Abstract available


  52. MICHAUD GF, Kumar S
    Surgical Ganglionic Plexus Ablation in Atrial Fibrillation: Is All Hope Lost for the Plexus?
    J Am Coll Cardiol. 2016;68:1166-8.
    PubMed     Text format    


  53. DRIESSEN AH, Berger WR, Krul SP, van den Berg NW, et al
    Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study.
    J Am Coll Cardiol. 2016;68:1155-65.
    PubMed     Text format     Abstract available


  54. TAMAYO SG, Simeone JC, Nordstrom BL, Patel MR, et al
    Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1144-6.
    PubMed     Text format    


    August 2016
  55. CURTIS JP, Akar JG
    A Fresh Perspective on Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:905-7.
    PubMed     Text format    


  56. SUTTON NR, Seth M, Ruwende C, Gurm HS, et al
    Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:895-904.
    PubMed     Text format     Abstract available


  57. OLDE NORDKAMP LR, Conte G, Rosenmoller BR, Warnaars JL, et al
    Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2016;68:665-6.
    PubMed     Text format    


  58. GRANGER CB, Thomas KL
    Stroke Prediction in Atrial Fibrillation: Is it Black and White?
    J Am Coll Cardiol. 2016;68:471-2.
    PubMed     Text format    


  59. KABRA R, Girotra S, Vaughan Sarrazin M
    Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    J Am Coll Cardiol. 2016;68:461-70.
    PubMed     Text format     Abstract available


    July 2016
  60. YAP SC, Ramjankhan F, Muslem R, de Jonge N, et al
    Ventricular Arrhythmias in Patients With a Continuous-Flow Left Ventricular Assist Device.
    J Am Coll Cardiol. 2016;68:323-5.
    PubMed     Text format    


  61. RAMOS R, Comas-Cufi M, Alves-Cabratosa L, Garcia-Gil M, et al
    Reply: Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:238.
    PubMed     Text format    


  62. KESER A, Ozbek K, Katlandur H, Ulucan S, et al
    Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:237-8.
    PubMed     Text format    


  63. DHRUVA SS, Redberg RF
    Sex-Specific Data for the Subcutaneous Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2016;68:133.
    PubMed     Text format    


  64. DEL-CARPIO MUNOZ F, Yao X, Abraham NS, Bellolio MF, et al
    Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:129-31.
    PubMed     Text format    


    June 2016
  65. NOSEWORTHY PA, Yao X, Shah ND, Gersh BJ, et al
    Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:3020-1.
    PubMed     Text format    


  66. DESHPANDE S, Wann LS
    Aspirin in Atrial Fibrillation: The Clot Thickens.
    J Am Coll Cardiol. 2016;67:2924-6.
    PubMed     Text format    


  67. HSU JC, Maddox TM, Kennedy K, Katz DF, et al
    Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    J Am Coll Cardiol. 2016;67:2913-23.
    PubMed     Text format     Abstract available


  68. HEIDENREICH PA, Solis P, Estes NA 3rd, Fonarow GC, et al
    2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2016 Jun 24. pii: S0735-1097(16)32400.
    PubMed     Text format    


  69. HAVAKUK O, Viskin S
    Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.
    J Am Coll Cardiol. 2016;67:2806-7.
    PubMed     Text format    


  70. PATANE S
    Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases.
    J Am Coll Cardiol. 2016;67:2805.
    PubMed     Text format    


  71. VOGLER J, Willems S, Steven D
    Reply: Persistent Atrial Fibrillation: Time to Stop Comparing Apples With Oranges: Atrial Fibrillation: Beyond the Pulmonary Veins.
    J Am Coll Cardiol. 2016;67:2701-2.
    PubMed     Text format    


  72. SCHRICKER AA, Krummen DE, Hsu JC
    Atrial Fibrillation: Beyond the Pulmonary Veins.
    J Am Coll Cardiol. 2016;67:2700-1.
    PubMed     Text format    


  73. PROVIDENCIA R, Lambiase PD
    Persistent Atrial Fibrillation: Time to Stop Comparing Apples With Oranges.
    J Am Coll Cardiol. 2016;67:2699-700.
    PubMed     Text format    


    May 2016
  74. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Reply: Cautionary Pulmonary Insufficiency in Ablation of Ventricular Arrhythmias From Pulmonary Sinus Cusps.
    J Am Coll Cardiol. 2016;67:2562.
    PubMed     Text format    


  75. REN JF, Callans DJ, Marchlinski FE
    Cautionary Pulmonary Insufficiency in Ablation of Ventricular Arrhythmias From Pulmonary Sinus Cusps.
    J Am Coll Cardiol. 2016;67:2560-2.
    PubMed     Text format    


  76. PIAZZA G, Karipineni N, Goldberg HS, Jenkins KL, et al
    Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2444-6.
    PubMed     Text format    


  77. ASHBURNER JM, Singer DE
    Reply: Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2319.
    PubMed     Text format    


  78. OVERVAD TF, Bronnum Nielsen P, Bjerregaard Larsen T
    Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2318-9.
    PubMed     Text format    


  79. VAN DEN HAM HA, Klungel OH, Singer DE, Leufkens HG, et al
    Reply: Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2317-8.
    PubMed     Text format    


  80. POTPARA TS, Olesen JB
    Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2316-7.
    PubMed     Text format    


  81. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Reply: Our Perspective on Ventricular Arrhythmias Originating From Pulmonary Sinus Cusp.
    J Am Coll Cardiol. 2016;67:2196-7.
    PubMed     Text format    


  82. YANG Y, Liu Q, Zhou S, Xiao Y, et al
    Our Perspective on Ventricular Arrhythmias Originating From Pulmonary Sinus Cusp.
    J Am Coll Cardiol. 2016;67:2195-6.
    PubMed     Text format    


  83. SAFDER TB, Badgett RG
    Predicting Stroke in Patients With Atrial Fibrillation: An Incomplete Picture Without Considering Quality of Anticoagulation.
    J Am Coll Cardiol. 2016;67:2192-3.
    PubMed     Text format    


    April 2016
  84. TJONG FV, Brouwer TF, Kooiman KM, Smeding L, et al
    Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator.
    J Am Coll Cardiol. 2016;67:1865-6.
    PubMed     Text format    


  85. VERMOND RA, Geelhoed B, Rienstra M
    Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded.
    J Am Coll Cardiol. 2016;67:1754-5.
    PubMed     Text format    


  86. ONAT A, Simsek B, Akbas T
    Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.
    J Am Coll Cardiol. 2016;67:1753-4.
    PubMed     Text format    


  87. ANGUERA I, Garcia-Alberola A, Dallaglio P, Toquero J, et al
    Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.
    J Am Coll Cardiol. 2016;67:1653-4.
    PubMed     Text format    


    March 2016
  88. WILDE AA, Postema PG
    Risk Stratification in Brugada Syndrome: The "Impossible" Made Possible?
    J Am Coll Cardiol. 2016;67:1441-3.
    PubMed     Text format    


  89. CALO L, Giustetto C, Martino A, Sciarra L, et al
    A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I.
    J Am Coll Cardiol. 2016;67:1427-40.
    PubMed     Text format     Abstract available


  90. CHEN LY, Agarwal SK, Norby FL, Gottesman RF, et al
    Persistent but not Paroxysmal Atrial Fibrillation Is Independently Associated With Lower Cognitive Function: ARIC Study.
    J Am Coll Cardiol. 2016;67:1379-80.
    PubMed     Text format    


  91. ELLIOTT AD, Pathak RK, Mahajan R, Lau DH, et al
    Reply: Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!
    J Am Coll Cardiol. 2016;67:1258-9.
    PubMed     Text format    


  92. HALLE M, Adams V, Edelmann F, Pieske B, et al
    Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!
    J Am Coll Cardiol. 2016;67:1257-8.
    PubMed     Text format    


  93. ARBELO E, Sarquella-Brugada G, Brugada J
    Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?
    J Am Coll Cardiol. 2016;67:1059-61.
    PubMed     Text format    


  94. MAZZANTI A, Maragna R, Faragli A, Monteforte N, et al
    Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.
    J Am Coll Cardiol. 2016;67:1053-8.
    PubMed     Text format     Abstract available


  95. POOLE JE, Singh JP, Birgersdotter-Green U
    QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy?
    J Am Coll Cardiol. 2016;67:1104-17.
    PubMed     Text format     Abstract available


    February 2016
  96. D'AVILA A, Singh SM
    Ventricular Tachycardia Ablation: Are We Winning the Battle But Losing the War?
    J Am Coll Cardiol. 2016;67:684-6.
    PubMed     Text format    


  97. MARCHLINSKI FE, Haffajee CI, Beshai JF, Dickfeld TM, et al
    Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
    J Am Coll Cardiol. 2016;67:674-83.
    PubMed     Text format     Abstract available


  98. MERCHANT FM, Quest T, Leon AR, El-Chami MF, et al
    Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients.
    J Am Coll Cardiol. 2016;67:435-44.
    PubMed     Text format     Abstract available


  99. LEWIS GF, Gold MR
    Safety and Efficacy of the Subcutaneous Implantable Defibrillator.
    J Am Coll Cardiol. 2016;67:445-54.
    PubMed     Text format     Abstract available


    January 2016
  100. KRACHLER B, Lindahl B
    Atrial Fibrillation Is an Obesity-Related Outcome, Requiring a Body Composition-Neutral Assessment of Cardiorespiratory Fitness.
    J Am Coll Cardiol. 2016;67:349.
    PubMed     Text format    


  101. PATHAK RK, Elliott AD, Mahajan R, Lau DH, et al
    Reply: Atrial Fibrillation Is an Obesity-Related Outcome, Requiring a Body Composition-Neutral Assessment of Cardiorespiratory Fitness.
    J Am Coll Cardiol. 2016;67:349-50.
    PubMed     Text format    


  102. GARDIN JM
    The Value of Left Ventricular Relative Wall Thickness in Predicting Ventricular Arrhythmia and Related Death.
    J Am Coll Cardiol. 2016;67:313-5.
    PubMed     Text format    


  103. BITON Y, Goldenberg I, Kutyifa V, Baman JR, et al
    Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2016;67:303-12.
    PubMed     Text format     Abstract available


  104. BLOOMGARDEN Z, Bansilal S
    A Diabetes-Atrial Fibrillation Conundrum: Does Duration Trump Glycemia?
    J Am Coll Cardiol. 2016;67:248-50.
    PubMed     Text format    


  105. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis.
    J Am Coll Cardiol. 2016;67:343-4.
    PubMed     Text format    


  106. ASHBURNER JM, Go AS, Chang Y, Fang MC, et al
    Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.
    J Am Coll Cardiol. 2016;67:239-47.
    PubMed     Text format     Abstract available


  107. HAVAKUK O, Viskin S
    A Tale of 2 Diseases: The History of Long-QT Syndrome and Brugada Syndrome.
    J Am Coll Cardiol. 2016;67:100-8.
    PubMed     Text format     Abstract available


  108. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:125.
    PubMed     Text format    


  109. EMMERT MY, Salzberg SP
    Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:124.
    PubMed     Text format    


    December 2015
  110. MILLER JD, Aronis KN, Chrispin J, Patil KD, et al
    Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2899-906.
    PubMed     Text format     Abstract available


  111. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Idiopathic Ventricular Arrhythmias Originating From the Pulmonary Sinus Cusp: Prevalence, Electrocardiographic/Electrophysiological Characteristics, and Catheter Ablation.
    J Am Coll Cardiol. 2015;66:2633-2644.
    PubMed     Text format     Abstract available


  112. SHERWOOD MW, Nessel CC, Hellkamp AS, Mahaffey KW, et al
    Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.
    J Am Coll Cardiol. 2015;66:2271-81.
    PubMed     Text format     Abstract available


  113. LIP GY, Lane DA
    Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors.
    J Am Coll Cardiol. 2015;66:2282-4.
    PubMed     Text format    


    November 2015
  114. PATHAK RK, Mahajan R, Lau DH, Sanders P, et al
    Reply: BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort.
    J Am Coll Cardiol. 2015;66:2265-6.
    PubMed     Text format    


  115. FIORAVANTI F, Brisinda D, Sorbo AR, Fenici R, et al
    BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort.
    J Am Coll Cardiol. 2015;66:2264-5.
    PubMed     Text format    


  116. VISKIN S, Havakuk O, Schwaber MJ
    Pro-Arrhythmic Effects of Noncardiac Medications: Lessons From Macrolide Antibiotics.
    J Am Coll Cardiol. 2015;66:2185-8.
    PubMed     Text format    


  117. CHENG YJ, Nie XY, Chen XM, Lin XX, et al
    The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk.
    J Am Coll Cardiol. 2015;66:2173-84.
    PubMed     Text format     Abstract available


  118. HOLMES DR JR
    Reply: Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2058.
    PubMed     Text format    


  119. MESSORI A, Trippoli S
    Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2056-8.
    PubMed     Text format    


  120. CAMPUZANO O, Brugada R
    Age, Genetics, and Fibrosis in the Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:1987-9.
    PubMed     Text format    


  121. NADEMANEE K, Raju H, de Noronha SV, Papadakis M, et al
    Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:1976-86.
    PubMed     Text format     Abstract available


    October 2015
  122. CAMM AJ, Savelieva I
    Stroke Risk Stratification in Patients With Atrial Fibrillation: Comme Ci, Comme Ca, Plus Ca Change....
    J Am Coll Cardiol. 2015;66:1860-3.
    PubMed     Text format    


  123. VAN DEN HAM HA, Klungel OH, Singer DE, Leufkens HG, et al
    Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    J Am Coll Cardiol. 2015;66:1851-9.
    PubMed     Text format     Abstract available


  124. MARON BJ, Udelson JE, Bonow RO, Nishimura RA, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scie
    J Am Coll Cardiol. 2015 Oct 27. pii: S0735-1097(15)06571.
    PubMed     Text format    


  125. PATHAK RK, Mehta AB, Lau DH, Sanders P, et al
    Reply: Going Over LEGACY With a Pinch of Salt.
    J Am Coll Cardiol. 2015;66:1946.
    PubMed     Text format    


  126. VALENTOVA M, Raad N, Anker SD
    Going Over LEGACY With a Pinch of Salt.
    J Am Coll Cardiol. 2015;66:1945.
    PubMed     Text format    


  127. ABRAMOWITZ Y, Jilaihawi H, Chakravarty T, Mack MJ, et al
    Mitral Annulus Calcification.
    J Am Coll Cardiol. 2015;66:1934-41.
    PubMed     Text format     Abstract available


  128. ZIPES DP, Link MS, Ackerman MJ, Kovacs RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiolog
    J Am Coll Cardiol. 2015 Oct 27. pii: S0735-1097(15)06577.
    PubMed     Text format    


  129. LINK MS, Estes NA 3rd, Maron BJ
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2015 Oct 27. pii: S0735-1097(15)06582.
    PubMed     Text format    


  130. GOPINATHANNAIR R, Etheridge SP, Marchlinski FE, Spinale FG, et al
    Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.
    J Am Coll Cardiol. 2015;66:1714-28.
    PubMed     Text format     Abstract available


    September 2015
  131. BUCH E, Shivkumar K
    Catheter Ablation of Atrial Fibrillation: Advent of Second-Generation Technologies.
    J Am Coll Cardiol. 2015;66:1361-3.
    PubMed     Text format    


  132. SAVINO JA 3RD, Halperin JL
    Age, Ethnicity, and Stroke Risk in Patients With Atrial Fibrillation: Another Stitch in the Patchwork.
    J Am Coll Cardiol. 2015;66:1348-9.
    PubMed     Text format    


  133. CHAO TF, Wang KL, Liu CJ, Lin YJ, et al
    Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.
    J Am Coll Cardiol. 2015;66:1339-47.
    PubMed     Text format     Abstract available


  134. DUKKIPATI SR, Cuoco F, Kutinsky I, Aryana A, et al
    Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation.
    J Am Coll Cardiol. 2015;66:1350-60.
    PubMed     Text format     Abstract available


  135. BONDE AN, Kamper AL, Olesen JB
    Reply: Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:1311.
    PubMed     Text format    


  136. CHAN PH, Siu CW
    Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:1310-1.
    PubMed     Text format    


  137. MILLER MA, Neuzil P, Dukkipati SR, Reddy VY, et al
    Leadless Cardiac Pacemakers: Back to the Future.
    J Am Coll Cardiol. 2015;66:1179-89.
    PubMed     Text format     Abstract available


  138. NELSON BW, Van Wagoner DR
    How Does Diazoxide Elicit Arrhythmias in Rats With Type 2 Diabetes?: Is This Effect Clinically Significant?
    J Am Coll Cardiol. 2015;66:1157-9.
    PubMed     Text format    


  139. XIE C, Hu J, Motloch LJ, Karam BS, et al
    The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2015;66:1144-56.
    PubMed     Text format     Abstract available


  140. VERMOND RA, Geelhoed B, Verweij N, Tieleman RG, et al
    Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    J Am Coll Cardiol. 2015;66:1000-7.
    PubMed     Text format     Abstract available


  141. THOMPSON PD
    Physical Fitness, Physical Activity, Exercise Training, and Atrial Fibrillation: First the Good News, Then the Bad.
    J Am Coll Cardiol. 2015;66:997-9.
    PubMed     Text format    


  142. KOWEY PR, Robinson VM
    Observing the Obvious.
    J Am Coll Cardiol. 2015;66:1008-10.
    PubMed     Text format    


    August 2015
  143. STAVRAKIS S, Humphrey MB, Po SS
    Reply: Vagal Modulation of Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:978.
    PubMed     Text format    


  144. MACHHADA A, Gourine AV, Ackland GL
    Vagal Modulation of Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:977-8.
    PubMed     Text format    


  145. DZESHKA MS, Lip GY, Snezhitskiy V, Shantsila E, et al
    Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications.
    J Am Coll Cardiol. 2015;66:943-59.
    PubMed     Text format     Abstract available


  146. GROSSE-WORTMANN L, Hamilton R
    Reply: The Value of Cardiac Magnetic Resonance Imaging in Evaluation of Pediatric Patients for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    J Am Coll Cardiol. 2015;66:874-875.
    PubMed     Text format    


  147. TE RIELE AS, Marcus FI, James CA, Murray BA, et al
    The Value of Cardiac Magnetic Resonance Imaging in Evaluation of Pediatric Patients for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    J Am Coll Cardiol. 2015;66:873-874.
    PubMed     Text format    


  148. GILL EA, Poole JE
    Will the Real Left Bundle Branch Block Please Stand Up?
    J Am Coll Cardiol. 2015;66:642-4.
    PubMed     Text format    


  149. RISUM N, Tayal B, Hansen TF, Bruun NE, et al
    Identification of Typical Left Bundle Branch Block Contraction by Strain Echocardiography Is Additive to Electrocardiography in Prediction of Long-Term Outcome After Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2015;66:631-41.
    PubMed     Text format     Abstract available


  150. HESS CN, Peterson ED, Peng SA, de Lemos JA, et al
    Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:616-27.
    PubMed     Text format     Abstract available


  151. ZHANG Y, Guallar E, Blasco-Colmenares E, Butcher B, et al
    Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.
    J Am Coll Cardiol. 2015;66:524-531.
    PubMed     Text format     Abstract available


    July 2015
  152. LIP GY, Skjoth F, Rasmussen LH, Nielsen PB, et al
    Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex).
    J Am Coll Cardiol. 2015;66:488-90.
    PubMed     Text format    


  153. MACFARLANE PW, Antzelevitch C, Haissaguerre M, Huikuri HV, et al
    The Early Repolarization Pattern: A Consensus Paper.
    J Am Coll Cardiol. 2015;66:470-7.
    PubMed     Text format     Abstract available


  154. LARSEN BS, Kumarathurai P, Falkenberg J, Nielsen OW, et al
    Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:232-241.
    PubMed     Text format     Abstract available


  155. MARCUS GM, Dewland TA
    Premature Atrial Contractions: A Wolf in Sheep's Clothing?
    J Am Coll Cardiol. 2015;66:242-4.
    PubMed     Text format    


  156. BOSMANS J, Bleiziffer S, Gerckens U, Wenaweser P, et al
    The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients.
    J Am Coll Cardiol. 2015;66:209-217.
    PubMed     Text format     Abstract available


  157. CONTE G, Sieira J, Ciconte G, de Asmundis C, et al
    Reply: Early Repolarization: A Risk Factor in Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:206-7.
    PubMed     Text format    


  158. STEINFURT J, Odening KE
    Early Repolarization: A Risk Factor in Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:205-6.
    PubMed     Text format    


  159. SANTANGELI P, Marchlinski FE
    Ventricular Ectopy as a Modifiable Risk Factor for Heart Failure and Death: "Deja Vu All Over Again" May Be a Good Thing.
    J Am Coll Cardiol. 2015;66:110-2.
    PubMed     Text format    


  160. DUKES JW, Dewland TA, Vittinghoff E, Mandyam MC, et al
    Ventricular Ectopy as a Predictor of Heart Failure and Death.
    J Am Coll Cardiol. 2015;66:101-9.
    PubMed     Text format     Abstract available


  161. HARADA M, Tadevosyan A, Qi X, Xiao J, et al
    Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression.
    J Am Coll Cardiol. 2015;66:47-58.
    PubMed     Text format     Abstract available


  162. HATEM SN
    Atrial Fibrillation and Obesity: Not Just a Coincidence.
    J Am Coll Cardiol. 2015;66:12-3.
    PubMed     Text format    


  163. KIM GE, Young LH
    AMPK and the Atrial Response to Metabolic Inhibition.
    J Am Coll Cardiol. 2015;66:59-61.
    PubMed     Text format    


  164. MAHAJAN R, Lau DH, Brooks AG, Shipp NJ, et al
    Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity.
    J Am Coll Cardiol. 2015;66:1-11.
    PubMed     Text format     Abstract available


    June 2015
  165. ZAIDI A, Sheikh N, Jongman JK, Gati S, et al
    Clinical Differentiation Between Physiological Remodeling and Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes With Marked Electrocardiographic Repolarization Anomalies.
    J Am Coll Cardiol. 2015;65:2702-11.
    PubMed     Text format     Abstract available


  166. ALLEN LA, Fonarow GC, Simon DN, Thomas LE, et al
    Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
    J Am Coll Cardiol. 2015;65:2691-8.
    PubMed     Text format     Abstract available


  167. DARDAS TF, Levy WC
    Digoxin: In the Cross Hairs Again.
    J Am Coll Cardiol. 2015;65:2699-701.
    PubMed     Text format    


  168. WAKS JW, Manning WJ
    Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?
    J Am Coll Cardiol. 2015;65:2624-7.
    PubMed     Text format    


  169. HOLMES DR JR, Doshi SK, Kar S, Price MJ, et al
    Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
    J Am Coll Cardiol. 2015;65:2614-23.
    PubMed     Text format     Abstract available


  170. PATHAK RK, Elliott A, Middeldorp ME, Meredith M, et al
    Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals with Atrial Fibrillation: The CARDIO-FIT Study.
    J Am Coll Cardiol. 2015 Jun 20. pii: S0735-1097(15)03339.
    PubMed     Text format     Abstract available


  171. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A Professional Societal Overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.
    J Am Coll Cardiol. 2015 Jun 20. pii: S0735-1097(15)02852.
    PubMed     Text format    


  172. ASINGER RW, Shroff GR
    Atrial Fibrillation and Renal Function: How High Is the Price of Anticoagulation?
    J Am Coll Cardiol. 2015;65:2494-5.
    PubMed     Text format    


  173. BOHM M, Ezekowitz MD, Connolly SJ, Eikelboom JW, et al
    Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial.
    J Am Coll Cardiol. 2015;65:2481-93.
    PubMed     Text format     Abstract available


  174. KOTTKAMP H, Bender R, Berg J
    Reply: Atrial Fibrosis: An Illusion or a True Key to Successful Ablation of Atrial Fibrillation?
    J Am Coll Cardiol. 2015;65:2465-6.
    PubMed     Text format    


  175. SRAMKO M, Kautzner J
    Atrial Fibrosis: An Illusion or a True Key to Successful Ablation of Atrial Fibrillation?
    J Am Coll Cardiol. 2015;65:2465.
    PubMed     Text format    


  176. ALLI O, Asirvatham S, Holmes DR Jr
    Strategies to incorporate left atrial appendage occlusion into clinical practice.
    J Am Coll Cardiol. 2015;65:2337-44.
    PubMed     Text format     Abstract available


    May 2015
  177. BARRETT TW, Vermeulen MJ, Self WH, Jenkins CA, et al
    Emergency department management of atrial fibrillation in the united states versus ontario, Canada.
    J Am Coll Cardiol. 2015;65:2258-60.
    PubMed     Text format    


  178. HIRSH BJ, Copeland-Halperin RS, Halperin JL
    Fibrotic Atrial Cardiomyopathy, Atrial Fibrillation, and Thromboembolism: Mechanistic Links and Clinical Inferences.
    J Am Coll Cardiol. 2015;65:2239-2251.
    PubMed     Text format     Abstract available


  179. PRYSTOWSKY EN, Padanilam BJ
    Treatment of atrial fibrillation: a weighty problem.
    J Am Coll Cardiol. 2015;65:2170-2.
    PubMed     Text format    


  180. STIERMAIER T, Eitel C, Denef S, Desch S, et al
    Prevalence and Clinical Significance of Life-Threatening Arrhythmias in Takotsubo Cardiomyopathy.
    J Am Coll Cardiol. 2015;65:2148-50.
    PubMed     Text format    


  181. MENTING ME, Cuypers JA, Opic P, Utens EM, et al
    The unnatural history of the ventricular septal defect: outcome up to 40 years after surgical closure.
    J Am Coll Cardiol. 2015;65:1941-51.
    PubMed     Text format     Abstract available


  182. MARON BJ, Rowin EJ, Casey SA, Link MS, et al
    Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    J Am Coll Cardiol. 2015;65:1915-28.
    PubMed     Text format     Abstract available


  183. WILBER DJ
    Long-Term Mortality After Ablation of Ischemic Ventricular Tachycardia: Not Inducible Is Not Enough.
    J Am Coll Cardiol. 2015;65:1960-3.
    PubMed     Text format    


  184. YOKOKAWA M, Kim HM, Baser K, Stevenson W, et al
    Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia.
    J Am Coll Cardiol. 2015;65:1954-9.
    PubMed     Text format     Abstract available


  185. PARTHIBAN N, Esterman A, Mahajan R, Twomey DJ, et al
    Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes.
    J Am Coll Cardiol. 2015 May 8. pii: S0735-1097(15)02028.
    PubMed     Text format     Abstract available


  186. CALKINS H, Awtry EH, Bunch TJ, Kaul S, et al
    COCATS 4 Task Force 11: Training in Arrhythmia Diagnosis and Management, Cardiac Pacing, and Electrophysiology.
    J Am Coll Cardiol. 2015;65:1854-65.
    PubMed     Text format    


    April 2015
  187. KELLY JP, Mentz RJ, Mebazaa A, Voors AA, et al
    Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials.
    J Am Coll Cardiol. 2015;65:1668-1682.
    PubMed     Text format     Abstract available


  188. BURKE MC, Gold MR, Knight BP, Barr CS, et al
    Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.
    J Am Coll Cardiol. 2015;65:1605-15.
    PubMed     Text format     Abstract available


  189. CHAO TF, Liu CJ, Chen SA
    Reply: one more "C" for CHA2DS2-VASc score.
    J Am Coll Cardiol. 2015;65:1603-4.
    PubMed     Text format    


  190. SIU CW
    One more "C" for CHA2DS2-VASc score?
    J Am Coll Cardiol. 2015;65:1602-3.
    PubMed     Text format    


  191. GOLD MR
    Are leadless pacemakers a niche or the future of device therapy?
    J Am Coll Cardiol. 2015;65:1505-8.
    PubMed     Text format    


  192. KNOPS RE, Tjong FV, Neuzil P, Sperzel J, et al
    Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial.
    J Am Coll Cardiol. 2015;65:1497-504.
    PubMed     Text format     Abstract available


  193. LIP GY, Skjoth F, Rasmussen LH, Larsen TB, et al
    Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
    J Am Coll Cardiol. 2015;65:1385-94.
    PubMed     Text format     Abstract available


    March 2015
  194. GLUCK T, Alter P
    Omega-3 highly unsaturated fatty acids and arrhythmia risk: influences of load conditions and a differential endogenous metabolism.
    J Am Coll Cardiol. 2015;65:1267-8.
    PubMed     Text format    


  195. ACKERMAN MJ, DeSimone CV
    Programmed electrical stimulation for patients with asymptomatic Brugada syndrome? The shock-filled debate continues.
    J Am Coll Cardiol. 2015;65:889-91.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: